期刊文献+

泛昔洛韦片的剂量耐受性、药动学与生物利用度 被引量:8

Dosage Tolerance,Pharmacokinetics and Bioavailability of Famciclovir Tablet
暂未订购
导出
摘要 目的:观察正常人口服泛昔洛韦片剂的剂量耐受性、药动学和生物利用度,提出安全的临床治疗剂量。方法:4 组( 每组6 人)健康人分别口服0-125g 、0-25g 、0-5g 、0-75g 泛昔洛韦片剂,进行剂量耐受性试验。用HPLC 法测定9 人分别口服国产和进口的泛昔洛韦(fa mciclovir) 片各0-25g 后血和尿的喷昔洛韦(penciclovir) 浓度。结果:口服0-125g ~0-75 g 泛昔洛韦片剂呈现良好的耐受性。口服0-25g 泛昔洛韦国产片除了与进口片有生物等效性外,药- 时曲线呈二房室开放模型,约1h 前达峰,Cm ax 2-20 m g/ L,T1/2α(1-01 ±1-51)h ,T1/2β(2-93 ±0-83)h ,V/F(55-1 ±27-8) L,24h 尿喷昔洛韦累积率为(66-3 ±15-3) % 。结论:国产泛昔洛韦片口服后具有吸收较快、喷昔洛韦在体内分布迅速而广泛、大部分经肾排泄的特点。单剂量口服泛昔洛韦良好的耐受性和药动学特点的事实,推荐口服泛昔洛韦0-125g ~0-75g 、1 日3 次的给药方案用于临床可能是安全的。 AIM:To make sure safe famciclovir dose by experiment of dose tolenance and pharmacokinetics METHODS:Domestic famciclovir tablets in a single dose(0.125、0.25、0.5 and 0.75g)were orally administered to 4 groups(3♂ and 3♀ in each group) of healthy volunteers,respectively,to observe dosage tolerance.The contents of penciclovir in plasma and urine were determined by HPLC method after 0.25g domestic famciclovir tablet and Famvir(famciclovir) tablet were orally given to 9 male healthy subjects with randomized-cross and auto-paired method,respectively RESULTS:The volunteers could tolerate this medication in dose of 0.125g~0.75g.No toxic reactions and abnormal results of experimental tests were found.The major pharmacokinetic characteristics were as follows C-T curve of penciclovir displayed open two-comparment model.Penciclovir peak concentration might reach within one hour following administration T1/2ka:(0.15±0.08)h,Cmax:(2.20±0.39)mg/L,T1/2α:(1.01±1.51)h,T1/2β:(2.93±0.83)h,V/F:(55.1±27.8)L,24h urine-accumulating excretion rate of penciclovir:(66.26±15.34)%.Pharmacokinetic parameters of Famvir and domestic famciclovir tablet about bioavailability could be described as follows:Tmax:(0.84±0.34) and( 0.93±0.40)h(P>0.05;bioequivalent test),Cmax:(2.22±0.66) and( 2.20±0.39)mg/L,AUC0~12h:(6.25±1.24) and (6.24±1.28)mg/(L·h),AUC0~∞:1.08 and 6.82±1.10mg/(L·h).The above-mentioned three parameters were no statistically significant(P<0.05;bioequivalent test),between domestic and imported products.Bioavailability of domestic famciclovir tablet was (101±15)%.CONCLUSION:Domestic famciclovir tablet has characteristics of rapid absorption,extensive distribution,mainly excreted via urine and is bioequivalent with Famvir.That fine tolerance to single dose of famciclovir and pharmacokinetic charateristics similar to Famvir showed that famciclovir in a dose of 0.125g~0.75g,3 times daily would be safe for clinical use.
出处 《中国药房》 CAS CSCD 2000年第1期29-31,共3页 China Pharmacy
关键词 泛昔洛韦 剂量耐受 药物动力学 生物利用度 famciclovir dosage tolerance pharmacokinetics bioavailability
  • 相关文献

参考文献8

  • 1Tyring S,Barbarash RA,Nahlik JE,et al.Fa mciclovior the treatm ent of acute herpes zoster effectson acute disease and postherpetic neuralgia[].Annal of International Medicine.1995
  • 2Faro S.A review of fa mciclovir in the managem ent ofgenital herpes[].Infectious Diseases in Obstetrics and Gynecology.1998
  • 3Main J,Brow n JL,Howells C,et al.A double blind ,placebo - controlled study to assess the effect of famciclovir on virus replication in patients with chronichepatitis B virus infection[].Journal of Viral Hepatitis.1996
  • 4Lau GK,Liang R,Wu PC,et al.Use of fa mciclo_vir to prevent HBV reactivation in HBsAgpositiverecipients after allogeneic bone m arrow transplantation[].Journal of Hepatology.1998
  • 5Gill KS.Wood MJ-The clinical pharm acokinetics offam ciclovir[].Clinical Pharmacokinetics.1996
  • 6Shaw T,Mok SS,Locarnini SA.Inhibition of hepatitisB virus DNA poly m erase by enantiom ers of penciclovirtriphosphate and metabolic basis for selective inhibitionof HBVreplication by penciclovir[].Hepatology.1996
  • 7Hong JJ,Elgart ML.Gastrointestinal co m plicationsof der mato mal herpes zoster successfully treated wi_th fam ciclovir and lactulose[].J Am Acad Derm_atol.1998
  • 8ru m packer C.The pharm acological profile of fa mciclovir[].Semin Derm atol.1996

同被引文献51

引证文献8

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部